openPR Logo
Press release

Diabetic Neuropathy Market Growth And Revenue Analysis By Top Players like - Eli Lilly and Company, GlaxoSmithKline, Pfizer, Johnson & Johnson

04-17-2019 04:43 PM CET | Health & Medicine

Press release from: Coherent Market Insights

Diabetic Neuropathy

Diabetic Neuropathy

Market Overview
Diabetic Neuropathy is the damage caused to the nerve due to diabetes which often leads to pain and numbness in feet or lower legs. The pain can be experienced in other parts of the body such as hips, wrist and back depending upon the effect of neuropathy. There are different types of neuropathy such as focal neuropathy, proximal neuropathy, peripheral neuropathy and autonomic neuropathy. An estimated 50% of diabetic population suffers from diabetic neuropathy across the globe. Further, as per CDC estimates, 6-7 people per 1000 diabetic population suffer from diabetic neuropathy in the U.S. Rise in aging population coupled with rise in prevalence of diabetes, the patient pool for diabetic neuropathy will increase significantly, in turn fueling growth of the diabetic neuropathy market.

Request For Sample Copy of This Research Report:

New drugs to treat neuropathy pain will alter the current market dynamics
The diabetic neuropathy market has been under continuous evolution from the past 5 years. There are generic drugs and specialty drugs including antidepressants and antispasmodics, as well to treat pain associated with the disorder. However, in 2011, there were an estimated 79 novel drugs in the clinical trial phase with Horizant (Gabapentin Enacarbil extended release) being one of the most effective drug. The pharmaceutical companies will continue the required geographic expansion and release novel drugs across major countries in different regions. Further, the growing awareness about diabetic neuropathy, increased healthcare spending and increase in pharmaceutical R&D spending will be important factors for growth in the diabetic neuropathy market.

Asia Pacific region will be the next frontier of growth in the global diabetic neuropathy market
North America is the largest market for diabetic neuropathy, with an estimated 35 million affected by the disease in U.S and Canada. The pharmaceutical companies continue to introduce novel drugs in the region in order to offset the generic drug erosion. Diabetic neuropathy treatment has gained immense traction especially in U.S. due to large patient pool, high incidence of diabetes and growing geriatric population. However, the strict regulatory scenario for drug approval in U.S. and Canada has been a challenge for the diabetic neuropathy market. Other factors such as significant rate of failure during clinical trials and long drug approval time continue to restrain the growth in industry.

Asia Pacific region is fastest growing region with countries such as India and China showing lucrative growth. India has one of the highest rates of diabetes type 2 in the world and according to an independent research, by year 2030, an estimated 80 million people will be affected with diabetes type 2 in India. Additionally, the study concluded that the prevalence rate for diabetic neuropathy was 29% in the entire patient population. China has edged India and has a diabetes patient population of 110 million which is projected to reach 150 million by 2040, as per data published by WHO. Major pharmaceutical companies are now venturing into Asia pacific region and the market is poised to witness substantial growth in the region due to large patient population, less stringent regulatory scenario, increasing R&D investment, growth in clinical trials conducted and government funding for the disease treatment.

The introduction of new players will change the existing market dynamics as they continue to compete with existing key players
The key players in the diabetic neuropathy market are Eli Lilly and Company, GlaxoSmithKline, Pfizer, Johnson & Johnson and Janssen Pharmaceuticals. Due to the high cost associated with the development of novel drugs and long regulatory approval time, the major players in the diabetic neuropathy industry acquire small players possessing unique drugs. The market is consolidated in nature with major pharmaceutical players accounting for major market share. As majority of current breed of drugs undergo patent expiration, the generic drugs will enter the market and the key competitors would have to introduce innovative products into the market to stay competitive.

Download The PDF Brochure:

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

1001 4th Ave,
Seattle, WA 98154
Tel: +1-206-701-6702

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Diabetic Neuropathy Market Growth And Revenue Analysis By Top Players like - Eli Lilly and Company, GlaxoSmithKline, Pfizer, Johnson & Johnson here

News-ID: 1707648 • Views: 1294

More Releases from Coherent Market Insights

Medical Alert Systems Market continues to witness growth with LifeStation introd …
Medical Alert Systems usually consists of a pendant worn on a necklace or around the neck which carries an LED light-emitting diode (LED) signal in case of emergency. A Medical Alert System also has a Medical Alert clasp attached to a bracelet which also gives out immediate emergency help by the push of a single button; this makes you immediately in touch with an authorized operator, who dispenses medical help
Alcohol Breathalyzer and Drug Testing Equipment Market – Insights And Opportun …
A breath analyzer, is also known as a Breathalyzer. It is a portable device used by the regulatory authorities across world to identify if suspect has consumed alcohol above the permitted limits. In developing and developed countries like U.S., India, China government are taking initiatives and enforcing safety laws related work safety issues. According to the Centers for Diseases and Prevention reports published in 2016 excessive alcohol use leads to
Home Healthcare Software Market continues to expand with rising cases of chronic …
Home healthcare software, sometimes called inpatient care software or domiciliary care software, falls into the wide category of healthcare information management. It is essentially an application that aids inpatient management and tracking such things as appointments, medications, doctor's notes, hospitalizations, and so forth. The program is designed for the individual or family caregiver to access the medical records of their patient and for the caregiver to upload these records into
Endocrine Testing Market Growth Is Attributed to Increasing Prevalence of Endocr …
Endocrine testing is an important diagnostic technique used to identify endocrine hormone level in the human body. It is utilized to diagnose hormone-related illnesses. Endocrine system consists of various glands such as pituitary gland, thyroid, pancreas, hypothalamus, and adrenal glands. Hormones secreted by these glands are used to maintain various biological functions of the body. Thus, imbalance in the concentrations of hormones may lead to certain conditions. Endocrine testing is

All 5 Releases

More Releases for Diabetic

Diabetic Food Market
Diabetes refers to a metabolic disease which leads to high blood sugar levels. The main cause behind diabetes is the insufficient insulin or no response in the body cells where the insulin is produced. Diabetic foods are dietary products rich in carbohydrates and sugar content. They help in controlling rising blood glucose. Diabetic food is low in calorie sweeteners and diet beverages. These products are consumed by diabetic patients and
Global Diabetic Care Devices Market
The global diabetes monitoring devices market generally consists of the following devices: self-glucose monitoring devices, blood glucose meter devices, blood glucose test strips, lancets and lancet devices, continuous glucose monitoring devices, transmitters and receivers. This report does not include other medical devices used in hospitals. To Get Sample Copy of Report visit @ The scope of the report includes an overview of the global market for diabetes monitoring devices and analyses
Expanding Diabetic Populace Driven Growth For Diabetic Food Market Globally
Market Overview Diabetic Food items are dietary items that incorporate diminished starch and sugar substance that assistance in controlling the ascent of the blood glucose. Diabetic Food additionally contains low calorie sweeteners, slim down refreshments, and so on. These items are devoured by diabetic individuals and by the general population who are not diabetic as careful step to avoid diabetes. Diabetic nourishment makers are entering into different market fragments by presenting
Diabetic Alcohol Swabs Market
An alcohol swab is gauze that has been dipped and saturated with alcohol. It is a vital part of any first aid kit. Alcohol swabs are primarily used to disinfect and clean cuts and scrapes. They are used in doctors’ clinics, diagnostic centers, and other places where quick and easy cleaning of a locale is desired. The alcohol in the alcohol swabs helps get rid of possible sources of contamination
Global Diabetic Retinopathy Market
The Diabetic Retinopathy Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. Diabetes is the chronic condition associated with abnormally high level of glucose in the blood. Insufficient or non production of insulin in pancreas causes diabetes. Globally, the incidence of diabetes is
Diabetic Food Market -
In recent times, diabetes has emerged as one of the most challenging health conditions across the world. According to the WHO, a total of 415 million cases of diabetes were reported globally in 2015. The count is rising at an alarming rate and is expected to reach 642 million in the next 25 years. Till now no medication has been found that can completely cure diabetes. It can only be